Inventor · disambiguated record
Alice Yam
Also filed as: YAM ALICE
15 granted patents·26 pending applications·45 citations·filing 2008–2024
89Inventor score
Top patents by PatentIndex Score
41 records- 0194US10596270B2Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugatesSUTRO BIOPHARMA INC·Filed 2018·Granted Mar 24, 2020·15 cites·24 claims
- 0292US11744876B2Immunomodulator antibody drug conjugates and uses thereofSUTRO BIOPHARMA INC·Filed 2020·Granted Sep 5, 2023·4 cites·47 claims
- 0392US10774354B2Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expressionSUTRO BIOPHARMA INC·Filed 2018·Granted Sep 15, 2020·9 cites·29 claims
- 0491US10190145B2Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expressionSUTRO BIOPHARMA INC·Filed 2014·Granted Jan 29, 2019·12 cites·20 claims
- 0582US11708413B2Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2017·Granted Jul 25, 2023·3 cites·29 claims
- 0682US2025090676A1Anti-folate receptor alpha antibody conjugates and their usesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0777US12144869B2Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2023·Granted Nov 19, 2024·0 cites·24 claims
- 0877US2025135025A1Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugatesSTURO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0977US2025018054A1Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1075US12226490B2Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary classSUTRO BIOPHARMA INC·Filed 2023·Granted Feb 18, 2025·0 cites·38 claims
- 1174US11993658B2Anti-BCMA antibodies and treatment methodsSUTRO BIOPHARMA INC·Filed 2019·Granted May 28, 2024·1 cites·16 claims
- 1273US2024409630A1Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and methods of making and using anti-folate receptor antibodiesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1372US12427201B2Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugatesSUTRO BIOPHARMA INC·Filed 2019·Granted Sep 30, 2025·0 cites·27 claims
- 1471US10975150B2Anti-CD74 antibodies, compositions comprising anti-CD74 antibodies and methods of using anti-CD74 antibodiesSUTRO BIOPHARMA INC·Filed 2015·Granted Apr 13, 2021·1 cites·29 claims
- 1571US2024182580A1Anti-cd74 antibody conjugates, compositions comprising anti cd74 antibody conjugates and methods of using anti-cd74 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1671US2024101631A1Human interleukin-2 conjugates biased for the interleukin-2 receptor beta-gammac dimer and conjugated to a nonpeptidic, water-soluble polymerMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1770US2024368295A1Anti-bcma antibodies and treatment methodsSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1869US2024139285A1Immunomodulator antibody drug conjugates and uses thereofSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1969US2025236674A9Anti-cd74 antibody conjugates, compositions comprising anti cd74 antibody conjugates and methods of using anti-cd74 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2068US12071477B2Anti-folate receptor alpha antibody conjugated with hemiasterlinsSUTRO BIOPHARMA INC·Filed 2018·Granted Aug 27, 2024·0 cites·26 claims
- 2165US11827684B2Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymerMERCK SHARP & DOHME LLC·Filed 2021·Granted Nov 28, 2023·0 cites·54 claims
- 2265US2021054429A1Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expressionSUTRO BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2364US2022106401A1ANTI-EpCAM ANTIBODIES, COMPOSITIONS COMPRISING ANTI-EpCAM ANTIBODIES AND METHODS OF MAKING AND USING ANTI-EpCAM ANTIBODIESSUTRO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2463US2024124585A1Anti-cd3 antibodies, compositions comprising anti-cd3 antibodies and methods of making and using anti-cd3 antibodiesSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2562US2021403558A1Anti-tim-3 antibodies, compositions comprising anti-tim-3 antibodies and methods of making and using anti-tim-3 antibodiesSUTRO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2661US2021284739A1Anti-cd74 antibodies, compositions comprising anti-cd74 antibodies and methods of using anti-cd74 antibodiesSUTRO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2760US2021107981A1Anti-pd-1 antibodies, compositions comprising anti-pd-1 antibodies and methods of using anti-pd-1 antibodiesSUTRO BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2855US10822414B2Anti-PD-1 antibodies, compositions comprising anti-PD-1 antibodies and methods of using anti-PD-1 antibodiesSUTRO BIOPHARMA INC·Filed 2015·Granted Nov 3, 2020·0 cites·35 claims
- 2954US2019233512A1Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and methods of making and using anti-folate receptor antibodiesSUTRO BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 3052US2023310629A1Bispecific antibody-drug conjugates targeting egfr and muc1 and uses thereofMERCK PATENT GMBH·Filed 2021·Application pending·0 cites
- 3150US11098131B2Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodiesSUTRO BIOPHARMA INC·Filed 2016·Granted Aug 24, 2021·0 cites·29 claims
- 3250US11014983B2Anti-Tim-3 antibodies, compositions comprising anti-Tim-3 antibodies and methods of making and using anti-Tim-3 antibodiesSUTRO BIOPHARMA INC·Filed 2016·Granted May 25, 2021·0 cites·27 claims
- 3348US2020190192A1Pd-1/tim-3 bi-specific antibodies, compositions thereof, and methods of making and using the sameSUTRO BIOPHARMA INC·Filed 2018·Application pending·0 cites
- 3448US2022323599A1Anti-bcma antibody conjugate, compositions comprising the same, and methods of making and using the sameCELGENE CORP·Filed 2020·Application pending·0 cites
- 3547US2022362394A1Anti-bcma antibody conjugatesSUTRO BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3647US2011189692A1Assay for pathogenic conformersNOVARTIS AG·Filed 2009·Application pending·0 cites
- 3744US2020079850A1Pd-1/lag3 bi-specific antibodies, compositions thereof, and methods of making and using the sameSUTRO BIOPHARMA INC·Filed 2018·Application pending·0 cites
- 3841US2010196934A1Prion assayPERETZ DAVID·Filed 2008·Application pending·0 cites
- 3940US2019330336A1Anti-lag3 antibodies, compositions comprising anti-lag3 antibodies and methods of making and using anti-lag3 antibodiesSUTRO BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 4035US2013273573A1Amyloid beta aggregates in cerebro spinal fluid as biomarkers for alzheimer's diseaseALLAUZEN SOPHIE·Filed 2010·Application pending·0 cites
- 4131US2013109581A1Positively charged species as binding reagents in the separation of protein aggregates from monomersPERETZ DAVID·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alice Yam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →